Zdrowie i gospodarka · 13/11/2001

FDA Releases Draft Guidance on Assessing Reproductive Toxicities of Drugs

The Food and Drug Administration (FDA) has made available a draft guidance document that outlines a process for evaluating the potential human reproductive and developmental risks associated with drug exposure, when definitive human data is not available.